Brief: Coloplast A/S - Coloplast Revises Financial Guidance For FY 2025/26 To Reflect Reduced Growth Outlook For Kerecis

Coloplast A/S

23/04/2026 18:57

April 23 (Reuters) - Coloplast A/S COLOb.CO:

COLOPLAST OUTLOOK FY ORGANIC GROWTH 5-6%

COLOPLAST - REVISES FY 2025/26 ORGANIC GROWTH AND EBIT GROWTH GUIDANCE

COLOPLAST - SEES FY 2025/26 ORGANIC GROWTH AT 5-6%, PRIOR AROUND 7%

COLOPLAST - SEES FY 2025/26 EBIT GROWTH IN CONSTANT CURRENCIES AT 5%, PRIOR AROUND 7%

COLOPLAST - SEES FY 2025/26 ROIC AFTER TAX BEFORE SPECIAL ITEMS AT 15%

COLOPLAST: GROUP ORGANIC GROWTH WAS 6% IN H1 AND EBIT(1) GROWTH IN CONSTANT CURRENCIES WAS 5%.

SEES FY 2025/26 SPECIAL ITEMS AT DKK 3.1 BLN

COLOPLAST - IMPAIRMENT LOSS OF DKK 3.0 BLN RECOGNISED AGAINST KERECIS GOODWILL, TOTAL CARRYING BOOK VALUE OF KERECIS AMOUNTS TO AROUND DKK 6 BILLION

Source text: ID:nGNE7X8nKd

Further company coverage: [COLOb.CO]

 ((Reuters.Briefs@thomsonreuters.com;))